|Articles|October 27, 2022
Boehringer Ingelheim Extends Use of Medidata Rave
Collaboration in EDC renewed for another five years.
Advertisement
Medidata and Boehringer Ingelheim announced a five-year renewal of their collaboration in the area of electronic data capture. The new agreement extends the use of Rave EDC for Boehringer Ingelheim's clinical trials worldwide and includes myMedidata.
Read more about the collaboration
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AbbVie and Genmab Secure FDA Approval for Epkinly Combination in Second-Line Plus Follicular Lymphoma
2
The Future is Now: Four Ways AI and Other Tech Advances are Enhancing Clinical Trials
3
Managing Operational and Compliance Challenges on Emerging Platforms
4
Ziihera Combinations Show Significant Survival Benefits in Phase III HER2+ GEA Trial
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
